Search clinical trials for: Grass pollen induced allergic rhinoconjunctivitis

Total 23184 results

ALK-Abelló A/S
Syneos Health

Completed

A Study in Adults With Grass Pollen-induced Rhinoconjunctivitis (Rhapsody)

Allergy

France, Estonia, Czechia, Lithuania, Poland, Latvia
Allergy Therapeutics

Completed

Efficacy and Safety of PQ Grass in Subjects With Seasonal Allergic Rhinitis and/or Rhinoconjunctivitis Induced by Grass Pollen

Seasonal Allergic Rhinitis | Rhinoconjunctivitis

United States, Germany, Austria, Hungary, Czechia, Poland
Marinomed Biotech AG

Completed

Demonstration of an Anti-allergic Effect in Subjects Treated With Callergin Nasal Spray in Comparison to Untreated Subjects and Subjects Treated With Vis Alpin® Alpensalz Nasal Spray, All Suffering From Grass Pollen Induced Rhinitis/Rhinoconjunctivitis

Allergic Rhinitis | Allergic Rhinoconjunctivitis

Austria
ASIT Biotech S.A.

Unknown

Clinical Efficacy and Safety of Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis

Hay Fever
BioTech Tools S.A.

Completed

Clinical Efficacy and Safety of a Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis

Hay Fever

Spain, Belgium, Italy
Queen's University
Merck Sharp & Dohme LLC

Completed

The Impact of Grass SLIT Treatment on Birch Pollen Induced Allergic Rhinitis - a Pilot Evaluation

Allergic Rhinoconjunctivitis

Canada
ALK-Abelló A/S

Completed

Evaluation of the Efficacy and Safety of AVANZ® Phleum Pratense in Grass Pollen-induced Allergic Rhinitis During Controlled Exposure in an Environmental Challenge Chamber (AV-G-03)

Grass Pollen Induced Allergic Rhinoconjunctivitis

Germany
Abbott

Completed

Study Immunology and Safety of 60-day Treatment of SQ Grass SLIT (Sublingual Immunotherapy)-Tablet in Adult Subjects With Grass Pollen-induced Allergic Rhinoconjunctivitis

Seasonal Allergic Rhinitis

Russian Federation
ALK-Abelló A/S
Ergomed; ACM Pivotal Global Central Laboratory; Brecon Pharmaceuticals Ltd

Completed

Comparison of Different Up-dosing Schedules With Osiris Phleum Pratense (Osiris)

Rhino-conjunctivitis

Poland
University of Aarhus
Aarhus University Hospital; Innovation Fund Denmark

Recruiting

A Motivation-enhancing App to Retain Patients With Hay Fever in a Trial After Treatment

Grass Pollen Allergy | Rhinoconjunctivitis

Denmark
Inmunotek S.L.

Recruiting

Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen

Rhinitis, Allergic | Rhinoconjunctivitis | Asthma, Allergic

Spain
Imperial College London
ALK-Abelló A/S

Completed

Factors Predicting Efficacy of Allergen Injection Immunotherapy for Grass Pollen Hayfever

Rhinitis, Allergic, Seasonal

United Kingdom
Stallergenes Greer

Active, not recruiting

Safety and Efficacy of STALORAL® Birch 300 IR in a Paediatric Population With Birch Pollen-induced ARC w/o Asthma (YOBI)

Allergic Rhinoconjunctivitis | Birch Pollen Allergy

Germany
Alyatec

Completed

Determination of Grass Pollen Allergen Concentration Inducing Rhinoconjunctivitis Symptoms in Subjects Allergic to Grass Pollen in ALYATEC Allergen Exposure Chamber

Allergic Rhinitis Due to Grass Pollen

France
Imperial College London
ALK-Abelló A/S

Completed

Grass Pollen Immunotherapy Using a Cluster Regime for Seasonal Rhinitis and Asthma

Rhinitis, Allergic, Seasonal

United Kingdom
ALK-Abelló A/S
Parexel

Completed

A Study in Children and Adolescents With Birch Pollen-induced Rhinoconjunctivitis (TreeTop)

Allergy

Hungary, Canada, Belgium, Poland, Austria, Germany, Denmark, Lithuania, Netherlands, Russian Federation, Slovakia
National Institute of Allergy and Infectious Diseases...
Regeneron Pharmaceuticals; PPD; Rho Federal Systems Division, Inc.; ALK-Abelló A/S and other collaborators

Active, not recruiting

Grass Pollen Immunotherapy Plus Dupilumab for Tolerance Induction (GRADUATE)

Grass Pollen Allergy | Allergic Rhinoconjunctivitis

United Kingdom
Inmunotek S.L.

Completed

Dose Finding for the Treatment of Rhinitis/Rhinoconjunctivitis Against Grass Pollen Allergy (MG56)

Rhinitis | Rhinoconjunctivitis

Spain
Aarhus University Hospital
University of Aarhus; University Hospital, Linkoeping

Active, not recruiting

Documentation of Efficacy of Intralymphatic Allergen Immunotherapy (ILITNU)

Allergic Rhinitis Due to Grass Pollen | Allergic Asthma | Allergic Conjunctivitis of Both Eyes

Denmark, Sweden
HAL Allergy

Completed

Efficacy and Safety of SUBLIVAC Phleum for Immunotherapy of Grass Pollen-Allergy

Allergic Rhinitis | Allergic Rhinoconjunctivitis

Canada
Merck Sharp & Dohme LLC

Completed

Efficacy and Safety Study of RAGWITEK™ (MK-3641) in Children With Ragweed-Induced Rhinoconjunctivitis With or Without Asthma (MK-3641-008)

Rhinitis, Allergic, Seasonal
Leti Pharma GmbH

Completed

Depigoid Birch 5000 Longterm Study in Adults and Adolescents

Allergic Rhinitis/Rhinoconjunctivitis +-Intermittent Asthma | Sensitization Against Betula Alba (Birch) Pollen

Germany
Stallergenes Greer
Venn Life Sciences

Completed

Observational Study of Oralair® in Children 5-9 Years With Grass-pollen-induced Allergic Rhinitis With/Without Conjunctivitis

Allergy

Germany
ALK-Abelló A/S

Completed

Molecular and Cellular Mechanism in the Course of Immunotherapy With a Phleum Pratense Oral Lyophilisate

Allergic Rhinitis Due to Grass Pollens

Spain
Roxall Medicina España S.A

Completed

Subcutaneous Immunotherapy in Patients Sensitized to Phleum Pratense

Allergic Rhinoconjunctivitis

Spain
ALK-Abelló A/S

Completed

Safety Study of MK-3641 and MK-7243 Co-administered in Adult Participants With Ragweed and Grass Pollen Induced Allergic Rhinitis (P08607, MK-3641-006)

Rhinitis, Allergic, Seasonal
HAL Allergy

Completed

SUBLIVAC FIX Birch Phase III Short-term Efficacy

Birch Pollen Induced Rhinitis/Rhinoconjunctivitis

Belgium, Germany, Czech Republic, Poland, Slovakia
Stallergenes Greer

Completed

Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Children Suffering From Grass Pollen Rhinoconjunctivitis

Allergy

Germany
Stallergenes Greer

Completed

Phase III Study to Assess the Long Term Efficacy, Carry-over Effect and Safety of 300 IR Sublingual Immunotherapy Tablets

Allergy

France
Stallergenes Greer

Completed

Safety and Efficacy on Phase III Study on 300 IR SLIT to Patients Suffering From Grass Pollen Rhinoconjunctivitis

Primary Disease

France, Italy, Spain
Stallergenes Greer

Completed

Safety and Efficacy of Sublingual Immunotherapy (SLIT) Tablets in Grass Pollen Rhinoconjunctivitis

Allergy
Stallergenes Greer

Completed

Efficacy and Safety of Sublingual Tablets of Grass Pollen Allergen Extract

Seasonal Allergic Rhinitis

Austria
Stallergenes Greer

Completed

Study of Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Adult Patients With Allergic Grass Pollen Rhinoconjunctivitis

Allergic Rhinitis Due to Grass Pollens

United States
Stallergenes Greer
Registrat-Mapi

Terminated

International Registry on the Quality of Life of Patients With Grass-pollen-induced Allergic Rhinitis (ALTO)

Allergic Rhinitis Due to Grass Pollens

France
University of Zurich
AlleCure

Completed

A Randomized Study to Evaluate a Novel Method of Specific Allergen Immunotherapy

Rhinoconjunctivitis Due to Grass Pollen Allergy

Switzerland
Allergopharma GmbH & Co. KG

Completed

Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in Children

Allergic Rhinoconjunctivitis

Germany
Charite University, Berlin, Germany

Completed

Vitamin D and Grass Pollen Specific Immunotherapy

Allergic Rhinoconjunctivitis

Germany
Aarhus University Hospital
University of Aarhus; ALK-Abelló A/S; Lundbeck Foundation

Completed

Changes in Specific Immunoglobulin and Blood Basophil Activity During Subcutaneous Immunotherapy in Allergic Rhinitis

Allergic Rhinoconjunctivitis
Allergopharma GmbH & Co. KG

Completed

2nd Pivotal Study rPhleum - Adults and Adolescents With Rhinoconjunctivitis +/-Controlled Asthma

Allergic Asthma | Rhinoconjunctivitis

Germany
BioTech Tools S.A.

Completed

Safety, Clinical Tolerability and Immunogenicity of Increasing Doses of gpASIT+TM

Hay Fever

Germany
Allergopharma GmbH & Co. KG

Completed

Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic Rhinoconjunctivitis

Grass Pollen Allergy

Germany
BioTech Tools S.A.

Completed

Safety and Tolerance Study of Grass Pollen-derived Peptides to Treat Allergic Rhinitis

Seasonal Allergic Rhinoconjunctivitis

Belgium
BioTech Tools S.A.

Completed

Clinical Efficacy and Safety of gpASIT+TM to Treat Seasonal Allergic Rhinoconjunctivitis

Hay Fever | Grass Pollen Allergy

Belgium, France, Luxembourg
BioTech Tools S.A.

Completed

Safety of gpASIT+TM Subcutaneously Administered to Hay Fever Patients With or Without Immunoregulating Adjuvant

Hay Fever

Belgium
Laboratorios Leti, S.L.

Completed

Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Grass Pollen

Seasonal Allergic Rhinitis

Spain, Hungary
Allergopharma GmbH & Co. KG

Completed

Safety and Efficacy of a Sublingual Specific Immunotherapy With an Extract of a Six Grass Pollen Mixture

Grass Pollen Allergy

Germany
Allergopharma GmbH & Co. KG

Completed

Evaluation of Safety and Efficacy of Specific Immunotherapy With Recombinant Major Allergens of Timothy Grass Pollen Adsorbed Onto Aluminium-hydroxide in Patients With IgE-mediated Allergic Rhinoconjunctivitis +/- Controlled Asthma (AMETHYST)

Rhinoconjunctivitis

Germany
HAL Allergy

Completed

SUBLIVAC FIX Phleum Pratense DT/DRF

Allergic Rhinitis | Allergic Rhinoconjunctivitis

Germany, Poland
Allergopharma GmbH & Co. KG

Completed

Safety and Efficacy of Recombinant Grass Pollen Allergen Cocktail in the Treatment of Allergic Rhinoconjunctivitis

Allergy

Germany
ALK-Abelló A/S

Completed

Compliance to the Treatment With GRAZAX® Tablets in Patients With Seasonal Grass Pollen Rhinoconjunctivitis (GT-17)

Allergic Rhinitis | Grass Allergy

Italy

3

Subscribe